Literature DB >> 24225358

High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III.

Alex R Chang1, Mariana Lazo, Lawrence J Appel, Orlando M Gutiérrez, Morgan E Grams.   

Abstract

BACKGROUND: Elevated serum phosphorus is associated with all-cause mortality, but little is known about risk associated with dietary phosphorus intake.
OBJECTIVE: We investigated the association between phosphorus intake and mortality in a prospective cohort of healthy US adults (NHANES III; 1998-1994).
DESIGN: Study participants were 9686 nonpregnant adults aged 20-80 y without diabetes, cancer, or kidney or cardiovascular disease. Exposure to dietary phosphorus, which was assessed by using a 24-h dietary recall, was expressed as the absolute intake and phosphorus density (phosphorus intake divided by energy intake). All-cause and cardiovascular mortality was assessed through 31 December 2006.
RESULTS: Median phosphorus intake was 1166 mg/d (IQR: 823-1610 mg/d); median phosphorus density was 0.58 mg/kcal (0.48-0.70 mg/kcal). Individuals who consumed more phosphorus-dense diets were older, were less often African American, and led healthier lifestyles (smoking, physical activity, and Healthy Eating Index). In analyses adjusted for demographics, cardiovascular risk factors, kidney function, and energy intake, higher phosphorus intake was associated with higher all-cause mortality in individuals who consumed >1400 mg/d [adjusted HR (95% CI): 2.23 (1.09, 4.5) per 1-unit increase in ln(phosphorus intake); P = 0.03]. At <1400 mg/d, there was no association. A similar association was seen between higher phosphorus density and all-cause mortality at a phosphorus density amount >0.35 mg/kcal [adjusted HR (95% CI): 2.27 (1.19, 4.33) per 0.1-mg/kcal increase in phosphorus density; P = 0.01]. At <0.35 mg/kcal (approximately the fifth percentile), lower phosphorus density was associated with increased mortality risk. Phosphorus density was associated with cardiovascular mortality [adjusted HR (95% CI): 3.39 (1.43, 8.02) per 0.1 mg/kcal at >0.35 mg/kcal; P = 0.01], whereas no association was shown in analyses with phosphorus intake. Results were similar by subgroups of diet quality and in analyses adjusted for sodium and saturated fat intakes.
CONCLUSIONS: High phosphorus intake is associated with increased mortality in a healthy US population. Because of current patterns in phosphorus consumption in US adults, these findings may have important public health implications.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24225358      PMCID: PMC3893724          DOI: 10.3945/ajcn.113.073148

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  43 in total

1.  Dietary phosphorus intake and mortality in moderate chronic kidney disease: NHANES III.

Authors:  Maureen A Murtaugh; Rebecca Filipowicz; Bradley C Baird; Guo Wei; Tom Greene; Srinivasan Beddhu
Journal:  Nephrol Dial Transplant       Date:  2011-08-02       Impact factor: 5.992

2.  Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations.

Authors:  Paul K Whelton; Lawrence J Appel; Ralph L Sacco; Cheryl A M Anderson; Elliott M Antman; Norman Campbell; Sandra B Dunbar; Edward D Frohlich; John E Hall; Mariell Jessup; Darwin R Labarthe; Graham A MacGregor; Frank M Sacks; Jeremiah Stamler; Dorothea K Vafiadis; Linda V Van Horn
Journal:  Circulation       Date:  2012-11-02       Impact factor: 29.690

3.  Serum phosphorus as a predictor of low-grade albuminuria in a general population without evidence of chronic kidney disease.

Authors:  Hajeong Lee; Se Won Oh; Nam Ju Heo; Ho Jun Chin; Ki Young Na; Suhnggwon Kim; Dong-Wan Chae
Journal:  Nephrol Dial Transplant       Date:  2012-01-18       Impact factor: 5.992

4.  Effects of phosphate binders in moderate CKD.

Authors:  Geoffrey A Block; David C Wheeler; Martha S Persky; Bryan Kestenbaum; Markus Ketteler; David M Spiegel; Matthew A Allison; John Asplin; Gerard Smits; Andrew N Hoofnagle; Laura Kooienga; Ravi Thadhani; Michael Mannstadt; Myles Wolf; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2012-07-19       Impact factor: 10.121

5.  Mineral metabolites and CKD progression in African Americans.

Authors:  Julia J Scialla; Brad C Astor; Tamara Isakova; Huiliang Xie; Lawrence J Appel; Myles Wolf
Journal:  J Am Soc Nephrol       Date:  2012-12-14       Impact factor: 10.121

6.  Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomes.

Authors:  Julie R Dominguez; Michael G Shlipak; Mary A Whooley; Joachim H Ix
Journal:  J Am Soc Nephrol       Date:  2013-03-21       Impact factor: 10.121

7.  Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004.

Authors:  Elizabeth Selvin; Jane Manzi; Lesley A Stevens; Frederick Van Lente; David A Lacher; Andrew S Levey; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2007-12       Impact factor: 8.860

8.  High dietary inorganic phosphate affects lung through altering protein translation, cell cycle, and angiogenesis in developing mice.

Authors:  Hua Jin; Seung-Hee Chang; Cheng-Xiong Xu; Ji-Young Shin; Youn-Sun Chung; Sung-Jin Park; Yeon-Sook Lee; Gil-Hwan An; Kee-Ho Lee; Myung-Haing Cho
Journal:  Toxicol Sci       Date:  2007-08-13       Impact factor: 4.849

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

Review 10.  Update on fibroblast growth factor 23 in chronic kidney disease.

Authors:  Myles Wolf
Journal:  Kidney Int       Date:  2012-05-23       Impact factor: 10.612

View more
  73 in total

1.  Phosphate toxicity: a stealth biochemical stress factor?

Authors:  Ronald B Brown; Mohammed S Razzaque
Journal:  Med Mol Morphol       Date:  2015-11-18       Impact factor: 2.309

2.  Phosphorus.

Authors:  Mona S Calvo; Christel J Lamberg-Allardt
Journal:  Adv Nutr       Date:  2015-11-13       Impact factor: 8.701

3.  The Kidney Dysfunction Epidemic, Part 1: Causes.

Authors:  Joseph Pizzorno
Journal:  Integr Med (Encinitas)       Date:  2015-12

Review 4.  Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.

Authors:  Julia J Scialla; Myles Wolf
Journal:  Nat Rev Nephrol       Date:  2014-04-01       Impact factor: 28.314

Review 5.  Dietary Phosphorus Intake and the Kidney.

Authors:  Alex R Chang; Cheryl Anderson
Journal:  Annu Rev Nutr       Date:  2017-06-14       Impact factor: 11.848

6.  Inclusion of Phosphorus in the Nutrition Facts Label.

Authors:  Lea Borgi
Journal:  Clin J Am Soc Nephrol       Date:  2018-11-30       Impact factor: 8.237

Review 7.  Epidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease.

Authors:  Julia J Scialla
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-05       Impact factor: 2.894

8.  Dietary phosphorus intake and blood pressure in adults: a systematic review of randomized trials and prospective observational studies.

Authors:  Scott T McClure; Casey M Rebholz; Sibyl Medabalimi; Emily A Hu; Zhe Xu; Elizabeth Selvin; Lawrence J Appel
Journal:  Am J Clin Nutr       Date:  2019-05-01       Impact factor: 7.045

9.  Fibroblast Growth Factor-23 and a Vegetarian Diet.

Authors:  Shuchi Anand; Ram Jagannathan; Ruby Gupta; Sailesh Mohan; Dorairaj Prabhakaran; Myles Wolf
Journal:  J Ren Nutr       Date:  2020-04-01       Impact factor: 3.655

10.  Serum phosphorus and mortality in the Third National Health and Nutrition Examination Survey (NHANES III): effect modification by fasting.

Authors:  Alex R Chang; Morgan E Grams
Journal:  Am J Kidney Dis       Date:  2014-06-14       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.